Impact of Neoadjuvant Chemotherapy on PD-L1 Expression in Oral Squamous Cell Carcinoma: A Matched Biopsy-Resection Study
{{output}}
Background: Programmed death ligand 1 (PD-L1) is essential for immune evasion and serves as a significant biomarker for immunotherapy in oral squamous cell carcinoma (OSCC). Nevertheless, the changes in its expression after neoad... ...
